The Immune Function Intervention Trial

Status Completed

Clinical Trial Summary

The purpose of the study is to examine whether cardiovascular exercise training improves immune responses to vaccination in previously sedentary older adults.

Clinical Trial Description

The extent to which exercise training or long-term physical activity influences poorly regulated immune function in the elderly is unclear. Preliminary evidence suggests that exercise training may improve various immune function measures in older adults. Although such findings have the potential to be of substantial public health importance, the majority of studies have suffered from small sample sizes, inadequate measurement of physical fitness, and weak research designs.

This study is designed to overcome these limitations by employing a longitudinal randomized controlled trial examining the effect of exercise training on clinically relevant immune function measures in older adults (65-80 years). Moreover, relationships between several factors known to be altered by exercise training and changes in immune function will be assessed. As such, there are two specific aims to be addressed. In Aim 1, a 10-month exercise trial will determine whether moderate intensity aerobic exercise training can improve immune function in previously sedentary older adults. In Aim 2, the role played by physiological, behavioral, and psychosocial factors in the relationship between exercise training and improved immune function will be examined.

150 sedentary participants will be randomly assigned to either a 10-month moderate aerobic exercise training program or a sedentary control group. Clinically relevant measures of immune function including the delayed-type hypersensitivity (DTH) response to a battery of antigens and the antibody response to tetanus toxoid and influenza virus vaccination will be assessed before, during and after the intervention. We hypothesize that exercise training will result in improved immune responses including higher peak antibody titers and DTH responses, and sustained levels of protective antibodies. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Immune Response

Clinical Trial Details

NCT number	NCT00548990
Study type	Interventional
Source	National Institute on Aging (NIA)
Contact
Status	Completed
Phase	N/A
Start date	August 2002
Completion date	July 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05515263` - Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination	N/A
Completed	`NCT02872311` - Open-Label Influenza Vaccine Evaluation	N/A
Completed	`NCT01861613` - Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students	Phase 4
Completed	`NCT03982069` - Immunologic Response to FluMist vs. Flucelvax	Phase 4
Recruiting	`NCT06041867` - Agaricus Bisporus and Influenza Vaccination Response	N/A
Completed	`NCT03614975` - Immunologic Response to Influenza Vaccination in Children and Adolescents	Phase 4
Completed	`NCT04573543` - The Role of Immune Semaphorins in NAFLD
Recruiting	`NCT03875703` - Post-Vaccination Biological Collection
Completed	`NCT00902278` - Immune Responses Induced by Different Licensed Influenza Vaccines	N/A
Completed	`NCT00346619` - Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults	Phase 1
Recruiting	`NCT04274348` - Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum	N/A
Active, not recruiting	`NCT05534893` - Effect of Blueberries on Immunity and Response to Flu Vaccination	N/A
Completed	`NCT05970887` - Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines	Phase 4
Completed	`NCT05706350` - Plant Stanol Esters and Influenza Vaccination	N/A
Completed	`NCT03167593` - Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.	Phase 2
Completed	`NCT04386408` - Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections	Phase 1
Completed	`NCT02933931` - Immune Durability After VSV-EBOV Vaccination
Recruiting	`NCT01289535` - Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years	Phase 4
Active, not recruiting	`NCT02441426` - Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development	N/A
Recruiting	`NCT03399357` - Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Immune Function Intervention Trial — ImFIT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms